181 related articles for article (PubMed ID: 16257854)
21. DNA copy number alterations and expression of relevant genes in mouse thymic lymphomas induced by gamma-irradiation and N-methyl-N-nitrosourea.
Kang HM; Jang JJ; Langford C; Shin SH; Park SY; Chung YJ
Cancer Genet Cytogenet; 2006 Apr; 166(1):27-35. PubMed ID: 16616109
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.
Torrey CE; Wall HG; Campbell JA; Kwanyuen P; Hoivik DJ; Miller RT; Allen JS; Jayo MJ; Selinger K; Santostefano MJ
Int J Toxicol; 2005; 24(5):327-39. PubMed ID: 16257852
[TBL] [Abstract][Full Text] [Related]
23. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
24. Early modification of c-myc, Ha-ras and p53 expressions by chemical carcinogens (DMBA, MNU).
Budán F; Varjas T; Nowrasteh G; Prantner I; Varga Z; Ember A; Cseh J; Gombos K; Pázsit E; Gobel G; Bauer M; Gracza T; Arany I; Perjési P; Ember I; Kiss I
In Vivo; 2009; 23(4):591-8. PubMed ID: 19567395
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic proliferative lesions in the spleen of rasH2 transgenic mice treated with MNU.
Long GG; Goodman DG; Credille KM; Mann PC; Wilson JM; Cardy R
Toxicol Pathol; 2010 Dec; 38(7):1026-36. PubMed ID: 20884814
[TBL] [Abstract][Full Text] [Related]
26. Induction of glandular stomach cancers in C3H mice treated with N-methyl-N-nitrosourea in the drinking water.
Tatematsu M; Yamamoto M; Iwata H; Fukami H; Yuasa H; Tezuka N; Masui T; Nakanishi H
Jpn J Cancer Res; 1993 Dec; 84(12):1258-64. PubMed ID: 8294216
[TBL] [Abstract][Full Text] [Related]
27. Effect of intragastric application of N-methylnitrosourea in p53 knockout mice.
Ohgaki H; Fukuda M; Tohma Y; Huang H; Stoica G; Tatematsu M; Donehower LA
Mol Carcinog; 2000 Jun; 28(2):97-101. PubMed ID: 10900466
[TBL] [Abstract][Full Text] [Related]
28. Tlag2, an N-methyl-N-nitrosourea susceptibility locus, maps to mouse chromosome 4.
Angel JM; Richie ER
Mol Carcinog; 2002 Feb; 33(2):105-12. PubMed ID: 11813303
[TBL] [Abstract][Full Text] [Related]
29. Early modification of c-myc, Ha-ras and p53 expressions by N-methyl-N-nitrosourea.
Budán F; Varjas T; Nowrasteh G; Varga Z; Boncz I; Cseh J; Prantner I; Antal T; Pázsit E; Gobel G; Bauer M; Gracza T; Perjési P; Ember I; Gyöngyi Z
In Vivo; 2008; 22(6):793-7. PubMed ID: 19181008
[TBL] [Abstract][Full Text] [Related]
30. p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis.
Yamamoto M; Tsukamoto T; Sakai H; Shirai N; Ohgaki H; Furihata C; Donehower LA; Yoshida K; Tatematsu M
Carcinogenesis; 2000 Oct; 21(10):1891-7. PubMed ID: 11023548
[TBL] [Abstract][Full Text] [Related]
31. Zinc-deficiency and the development of malignant lymphoma in rats given a single intragastric dose of N-methyl-N-nitrosourea.
Fong LY; Lui CP; Ma-Tung L; Ng WL
IARC Sci Publ; 1987; (84):261-3. PubMed ID: 3679381
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of nonthreshold leukemogenic response to methyl nitrosourea in p53-deficient C3H/He mice.
Hirabayashi Y; Yoshida K; Aizawa S; Kodama Y; Kanno J; Kurokawa Y; Yoshimura I; Inoue T
Toxicol Appl Pharmacol; 2003 Aug; 190(3):251-61. PubMed ID: 12902196
[TBL] [Abstract][Full Text] [Related]
33. Binding of labeled N-methyl N-nitrosourea to macromolecules of squamous and glandular stomach of rats.
Rao MS; Reddy JK
Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):373-6. PubMed ID: 981794
[TBL] [Abstract][Full Text] [Related]
34. The utility of the K6/ODC transgenic mouse as an alternative short term dermal model for carcinogenicity testing of pharmaceuticals.
Miller TJ; Honchel R; Espandiari P; Knapton A; Zhang J; Sistare FD; Hanig JP
Regul Toxicol Pharmacol; 2008 Feb; 50(1):87-97. PubMed ID: 18069108
[TBL] [Abstract][Full Text] [Related]
35. Carcinogenicity of N-methyl-N-nitrosourea and N-ethyl-N-nitrosourea when applied to a localized area of the hamster trachea.
Grubbs CJ; Becci PJ; Thompson HJ; Moon RC
J Natl Cancer Inst; 1981 May; 66(5):961-5. PubMed ID: 6939938
[TBL] [Abstract][Full Text] [Related]
36. Detection of micronucleated cells and gene expression changes in glandular stomach of mice treated with stomach-targeted carcinogens.
Okada E; Fujiishi Y; Yasutake N; Ohyama W
Mutat Res; 2008 Nov; 657(1):39-42. PubMed ID: 18805506
[TBL] [Abstract][Full Text] [Related]
37. The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI.
MacDonald J; French JE; Gerson RJ; Goodman J; Inoue T; Jacobs A; Kasper P; Keller D; Lavin A; Long G; McCullough B; Sistare FD; Storer R; van der Laan JW
Toxicol Sci; 2004 Feb; 77(2):188-94. PubMed ID: 14657512
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of potential human carcinogenicity of the synthetic monomer ethyl acrylate.
Williams GM; Iatropoulos MJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):6-15. PubMed ID: 18930102
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
40. Alternative mouse models for carcinogenicity assessment: industry use and issues with pathology interpretation.
Long GG; Morton D; Peters T; Short B; Skydsgaard M
Toxicol Pathol; 2010 Jan; 38(1):43-50. PubMed ID: 19915137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
